Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby renews consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Warfarin sodium 1 mg, 2 mg, 2.5 mg, 5 mg Tablets The Boots Company (Australia) Pty Limited, North Rocks, New South Wales, Australia Coumadin [et] This medicine may only be distributed, supplied or used under the following conditions: 1. The product is not to be marketed as substitutable for Marevan as if the two (2) products were bioequivalent; and 2. Prescribers are to be advised that when starting on Coumadin the dosage for each patient should be individually titrated according to therapeutic response determined by monitoring appropriate coagulation parameter. [rt] BCG strain Tice 2-8x10 cfu Powder for reconstitution for injection Organon Teknika Corporation, Durham, North Carolina, United States of America OncoTice Dated this 20th day of October 1993. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.